Malignancy and rheumatoid arthritis

被引：32

作者：

Askling J. ^{[1
]}

机构：

[1] Clinical Epidemiology Unit M9:01, Department of Medicine Solna, Karolinska University Hospital Solna

来源：

Current Rheumatology Reports | 2007年 / 9卷 / 5期

关键词：

Rheumatoid Arthritis; Cancer Risk; Abatacept; Cancer Occurrence; Rheumatoid Arthritis Treatment;

D O I：

10.1007/s11926-007-0067-1

中图分类号：

学科分类号：

摘要：

The occurrence of cancer is not an infrequent event in patients with rheumatoid arthritis (RA). Indeed, following diagnosis of RA at a typical age (55 years), one in five patients will be diagnosed with cancer. In the vast majority of such cases, the cancer has nothing to do with RA or its treatment; rather, it represents the "background" risk applicable to all humans. In some cases, the cancer occurs as a result of factors also associated with the risk of developing RA (eg, smoking), even though no direct link exists between the cancer and the RA. In a fraction of cases, however, the cancer is causally associated with the RA disease or its treatments. This review summarizes our current understanding of the occurrence of cancer in RA, possible links to RA disease and to traditional and newer RA treatments. Copyright © 2007 by Current Medicine Group LLC.

引用

页码：421 / 426

页数：5

共 45 条

[41] Cohen S.B., Emery P., Greenwald M.W., Et al., Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks, Arthritis Rheum, 54, pp. 2793-2806, (2006)
[42] Annex I: Summary of Product Characteristics
[43] Weinblatt M., Combe B., Covucci A., Et al., Safety of the selective costimulation modulator abatacept in rheumatoid arthritis patients receiving background biologic and non-biologic disease-modifying antirheumatic drugs: A one-year randomized, placebo-controlled study, Arthritis Rheum, 54, pp. 2807-2816, (2006)
[44] Morel J., Deschamps V., Toussirot E., Et al., Characteristics and survival of 26 patients with paraneoplastic arthritis, Ann Rheum Dis, (2007)
[45] Mikuls T.R., Endo J.O., Puumala S.E., Et al., Prospective study of survival outcomes in Non-Hodgkin's lymphoma patients with rheumatoid arthritis, J Clin Oncol, 24, pp. 1597-1602, (2006)

← 1 2 3 4 5 →